Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lanthanide Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1618787A details a green synthesis of 2-hydroxy-5-amidobenzophenones using Yb(OTf)3. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel SmI2-catalyzed reductive deuteration of nitriles offers high yield and regioselectivity. A cost-effective supply chain solution for deuterated drug manufacturing.
Patent CN112430187A reveals a novel SmI2-catalyzed reductive deuteration method for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN113292393A reveals a mild SmI2-catalyzed reductive deuteration of acyl fluorides. This method offers high deuterium incorporation and superior chemoselectivity for manufacturing deuterated pharmaceutical intermediates.